China Gives Conditional Approval For Pfizer COVID Pill Paxlovid
15 de feb. de 2022 ·
56s
Descarga y escucha en cualquier lugar
Descarga tus episodios favoritos y disfrútalos, ¡dondequiera que estés! Regístrate o inicia sesión ahora para acceder a la escucha sin conexión.
Descripción
China says it has given conditional approval for Pfizer’s COVID-19 drug Paxlovid to treat adults with mild to moderate illness and a high risk of developing severe disease. Pfizer says...
mostra más
China says it has given conditional approval for Pfizer’s COVID-19 drug Paxlovid to treat adults with mild to moderate illness and a high risk of developing severe disease.
Pfizer says that preliminary studies show that Paxlovid does not target the ever-evolving spike protein the coronavirus uses to invade cells, meaning it should theoretically be more variant-proof.
China’s National Medical Products Administration says further research on the drug needed to be undertaken and submitted to the regulator.
Beijing has not yet approved any foreign-made coronavirus vaccines.
mostra menos
Pfizer says that preliminary studies show that Paxlovid does not target the ever-evolving spike protein the coronavirus uses to invade cells, meaning it should theoretically be more variant-proof.
China’s National Medical Products Administration says further research on the drug needed to be undertaken and submitted to the regulator.
Beijing has not yet approved any foreign-made coronavirus vaccines.
Información
| Autor | Africa Business Radio |
| Página web | - |
| Etiquetas |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company
